Editorial: Experimental biology and medicine: new frontiers
Experimental Biology and Medicine · 2024
DOI: 10.3389/ebm.2024.10069 ↗Kurz gefasst
Editorial in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Steven R Goodman. Beteiligte Einrichtung: Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States. Hauptthemen laut MEDLINE: Medicine. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proceedings of the Society of Experimental Biology and Medicine was renamed Experimental Biology and Medicine (EBM) in 2001.I was honored to be selected as the Editor-in-Chief of EBM in 2006, with my first issue published in July of that year.When being interviewed for the position of Editor-in-Chief, I stated two goals: 1) to expand the number of categories from the seven that existed in 2006 by adding cutting edge interdisciplinary and multidisciplinary new categories and 2) to globalize the journal and, in so doing, globalize the Society.We have accomplished both goals over the last 17 years.EBM now has twenty-two categories to which authors can submit manuscripts that encompass the breadth of modern biomedical research.Our categories cover the entire translational spectrum including basic, preclinical, clinical, clinical trial and population research.EBM's focus is on biomedical research that is relevant to the practice of medicine.We publish original research articles, Brief Communications, Reviews, Mini Reviews, and at the Editor-in-Chief's discretion Commentaries and Editorials.In terms of global expansion EBM/SEBM now has offices and Global Editors on the six habitable continents.In addition to its US offices in Memphis, Tennessee, College Station, Texas, and Washington DC; EBM/SEBM now has offices in Taiwan (Tainan), the United Kingdom (London), China (Chengdu), Brazil (Campinas), Ghana (Accra), and Australia (Perth).The current 180 members of the Editorial Board are outstanding scientists coming from the global research community.With the accomplishments of broadening the scope and coverage of our categories and expanding to all habitable continents, EBM submissions have grown by over 6-fold since my becoming Editor-in-Chief, with the correlated growth of the impact of our content.EBM is unique in its broad range of topical areas and its coverage of the complete translational research spectrum.I believe that building upon its strong history and current direction, EBM will become the premier journal that publishes biomedical research that has a direct impact on the practice of modern medicine.The new EBM-Frontiers partnership is
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, United States.
Zitieren
APA
Goodman, S. R. (2024). Editorial: Experimental biology and medicine: new frontiers. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10069
Vancouver
Goodman SR. Editorial: Experimental biology and medicine: new frontiers. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10069
BibTeX
@article{Goodman2024,
author = {Goodman, Steven R},
title = {Editorial: Experimental biology and medicine: new frontiers},
journal = {Experimental Biology and Medicine},
year = {2024},
doi = {10.3389/ebm.2024.10069}
}
EUVIMED